Endocrine Disorders: Evaluation and Management
Summary
- Patients at risk for progression to diabetes mellitus and cardiovascular disease require close monitoring, including those who meet the following criteria:
- Impaired fasting glucose, defined as a fasting glucose concentration of 100-125 mg/dL
- Impaired glucose tolerance, defined as a 2-hour glucose concentration during an oral glucose tolerance test of 140-199 mg/dL
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Endocrine Disorders, Insulin Resistance